Metabolic cardiomyopathy in pediatrics.
Tril VE, Burlutskaya AV, Polischuk LV.
Rev Cardiovasc Med. 2019 Jun 30;20(2):73-80. doi: 10.31083/j.rcm.2019.02.5151.
Inflammation and metabolic cardiomyopathy.
Nishida K, Otsu K.
Cardiovasc Res. 2017 Mar 15;113(4):389-398. doi: 10.1093/cvr/cvx012.
Metabolic and Molecular Imaging of the Diabetic Cardiomyopathy.
Peterson LR, Gropler RJ.
Circ Res. 2020 May 22;126(11):1628-1645. doi: 10.1161/CIRCRESAHA.120.315899. Epub 2020 May 21.
Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy.
Chen Z, Jin ZX, Cai J, Li R, Deng KQ, Ji YX, Lei F, Li HP, Lu Z, Li H.
J Mol Med (Berl). 2022 Dec;100(12):1721-1739. doi: 10.1007/s00109-022-02269-1. Epub 2022 Nov 17.
Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management.
Meyers DE, Basha HI, Koenig MK.
Tex Heart Inst J. 2013;40(4):385-94.
Ferroptosis in mitochondrial cardiomyopathy.
Ahola S, Langer T.
Trends Cell Biol. 2024 Feb;34(2):150-160. doi: 10.1016/j.tcb.2023.06.002. Epub 2023 Jul 5.
Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis.
Fang X, Cai Z, Wang H, Han D, Cheng Q, Zhang P, Gao F, Yu Y, Song Z, Wu Q, An P, Huang S, Pan J, Chen HZ, Chen J, Linkermann A, Min J, Wang F.
Circ Res. 2020 Jul 31;127(4):486-501. doi: 10.1161/CIRCRESAHA.120.316509. Epub 2020 Apr 30.
Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy.
Peng ML, Fu Y, Wu CW, Zhang Y, Ren H, Zhou SS.
Front Endocrinol (Lausanne). 2022 Jun 15;13:907757. doi: 10.3389/fendo.2022.907757. eCollection 2022.
Heart Metabolism in Sepsis-Induced Cardiomyopathy-Unusual Metabolic Dysfunction of the Heart.
Wasyluk W, Nowicka-Stążka P, Zwolak A.
Int J Environ Res Public Health. 2021 Jul 16;18(14):7598. doi: 10.3390/ijerph18147598.
Metabolic dysfunction in diabetic cardiomyopathy.
Isfort M, Stevens SC, Schaffer S, Jong CJ, Wold LE.
Heart Fail Rev. 2014 Jan;19(1):35-48. doi: 10.1007/s10741-013-9377-8.
